1
|
Yan K, Kudo A, Hirano H, Watanabe T,
Tasaka T, Kataoka S, Nakajima N, Nishibori Y, Shibata T, Kohsaka T,
et al: Subcellular localization of glucocorticoid receptor protein
in the human kidney glomerulus. Kidney Int. 56:65–73. 1999.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Goodwin JE: Role of the glucocorticoid
receptor in glomerular disease. Am J Physiol Renal Physiol.
317:F133–F136. 2019. View Article : Google Scholar : PubMed/NCBI
|
3
|
Lu DF, Moon M, Lanning LD, McCarthy AM and
Smith RJH: Clinical features and outcomes of 98 children and adults
with dense deposit disease. Pediatr Nephrol. 27:773–781. 2012.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Barrett CMF, Troxell ML, Larsen CP and
Houghton DC: Membranous glomerulonephritis with crescents. Int Urol
Nephrol. 46:963–971. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Sharmeen S, Cassol C and Kato H:
ANCA-associated necrotizing glomerulonephritis overlapping with
mesangial proliferative lupus nephritis refractory to
plasmapheresis, steroid pulse therapy, and a combination of
mycophenolate mofetil and rituximab. Case Rep Rheumatol.
2018:30768062018.PubMed/NCBI
|
6
|
Wu X, Zhang M, Huang X, Zhang L, Zeng C,
Zhang J, Liu Z and Tang Z: Therapeutic mechanism of glucocorticoids
on cellular crescent formation in patients with antiglomerular
basement membrane disease. Am J Med Sci. 354:145–151. 2017.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Jiang L, Hindmarch CCT, Rogers M, Campbell
C, Waterfall C, Coghill J, Mathieson PW and Welsh GI: RNA
sequencing analysis of human podocytes reveals glucocorticoid
regulated gene networks targeting non-immune pathways. Sci Rep.
6:356712016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Bazsó A, Szappanos Á, Rásonyi R, Nagy E,
Farkas A, Várnai B, Patócs A, Kiss E and Poór G: Polymorphisms of
human glucocorticoid receptor gene in systemic lupus erythematosus:
A single-centre result. Clin Rheumatol. 38:1979–1984. 2019.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Rahbar Saadat Y, Hejazian SM,
Nariman-Saleh-Fam Z, Bastami M, Poursheikhani A, M Shoja M, Ardalan
M and Zununi Vahed S: Glucocorticoid receptors and their upstream
epigenetic regulators in adults with steroid-resistant nephrotic
syndrome. Biofactors. 46:995–1005. 2020. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ponticelli C and Locatelli F:
Glucocorticoids in the treatment of glomerular diseases: Pitfalls
and pearls. Clin J Am Soc Nephrol. 13:815–822. 2018. View Article : Google Scholar : PubMed/NCBI
|
11
|
Evans RM: The steroid and thyroid hormone
receptor superfamily. Science. 240:889–895. 1988. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zhou J and Cidlowski JA: The human
glucocorticoid receptor: One gene, multiple proteins and diverse
responses. Steroids. 70:407–417. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
De Bosscher K, Vanden Berghe W and
Haegeman G: The interplay between the glucocorticoid receptor and
nuclear factor-kappaB or activator protein-1: Molecular mechanisms
for gene repression. Endocr Rev. 24:488–522. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wilkenfeld SR, Lin C and Frigo DE:
Communication between genomic and non-genomic signaling events
coordinate steroid hormone actions. Steroids. 133:2–7. 2018.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Gamal Y, Badawy A, Swelam S, Tawfeek MSK
and Gad EF: Glomerular glucocorticoid receptors expression and
clinicopathological types of childhood nephrotic syndrome. Fetal
Pediatr Pathol. 36:16–26. 2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Han SH, Park SY, Li JJ, Kwak SJ, Jung DS,
Choi HY, Lee JE, Moon SJ, Kim DK, Han DS and Kang SW: Glomerular
glucocorticoid receptor expression is reduced in late responders to
steroids in adult-onset minimal change disease. Nephrol Dial
Transplant. 23:169–175. 2008. View Article : Google Scholar : PubMed/NCBI
|
17
|
Wang H, Gou X, Jiang T and Ouyang J: The
effects of microRNAs on glucocorticoid responsiveness. J Cancer Res
Clin Oncol. 143:1005–1011. 2017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Clayton SA, Jones SW, Kurowska-Stolarska M
and Clark AR: The role of microRNAs in glucocorticoid action. J
Biol Chem. 293:1865–1874. 2018. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kidney Disease: Improving Global Outcomes
(KDIGO) Glomerular Diseases Work Group: KDIGO 2021 clinical
practice guideline for the management of glomerular diseases.
Kidney Int. 100((4S)): S1–S276. 2021.PubMed/NCBI
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Gladman DD, Urowitz MB, Doris F,
Lewandowski K and Anhorn K: Glucocorticoid receptors in systemic
lupus erythematosus. J Rheumatol. 18:681–684. 1991.PubMed/NCBI
|
22
|
Oshima H: Studies on the glucocorticoid
receptor in human peripheral lymphocytes. II. Regulation by
glucocorticoid. Nihon Naibunpi Gakkai Zasshi. 62:1298–1305.
1986.(In Japanese). PubMed/NCBI
|
23
|
Oikonomidou O, Vlachoyiannopoulos PG,
Kominakis A, Kalofoutis A, Moutsopoulos HM and Moutsatsou P:
Glucocorticoid receptor, nuclear factor kappaB, activator protein-1
and C-jun N-terminal kinase in systemic lupus erythematosus
patients. Neuroimmunomodulation. 13:194–204. 2006. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kino T, De Martino MU, Charmandari E,
Mirani M and Chrousos GP: Tissue glucocorticoid
resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol.
85:457–467. 2003. View Article : Google Scholar : PubMed/NCBI
|
25
|
Zahran AM, Aly SS, Elsayh KI, Badawy A and
Gamal Y: Glucocorticoid receptors expression and histopathological
types in children with nephrotic syndrome. Ren Fail. 36:1067–1072.
2014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Shalaby SA, El Idrissy HM, Safar RA and
Hussein ST: Glucocorticoid receptors and the pattern of steroid
response in idiopathic nephrotic syndrome. Arab J Nephrol
Transplant. 5:13–17. 2012.PubMed/NCBI
|
27
|
Kee YK, Nam BY, Jhee JH, Park JT, Lim BJ,
Yoo TH, Kang SW, Jeong HJ and Han SH: The association of glomerular
glucocorticoid receptor expression with responsiveness to
corticosteroid treatment in IgA nephropathy. Am J Nephrol.
50:187–195. 2019. View Article : Google Scholar : PubMed/NCBI
|
28
|
Xian Y, Dong L, Jia Y, Lin Y, Jiao W and
Wang Y: miR-370 promotes high glucose-induced podocyte injuries by
inhibiting angiotensin II type 1 receptor-associated protein. Cell
Biol Int. 42:1545–1555. 2018. View Article : Google Scholar : PubMed/NCBI
|
29
|
Lal A, Pan Y, Navarro F, Dykxhoorn DM,
Moreau L, Meire E, Bentwich Z, Lieberman J and Chowdhury D:
miR-24-mediated downregulation of H2AX suppresses DNA repair in
terminally differentiated blood cells. Nat Struct Mol Biol.
16:492–498. 2009. View Article : Google Scholar : PubMed/NCBI
|
30
|
Manvati S, Mangalhara KC, Kalaiarasan P,
Srivastava N and Bamezai RNK: miR-24-2 regulates genes in survival
pathway and demonstrates potential in reducing cellular viability
in combination with docetaxel. Gene. 567:217–224. 2015. View Article : Google Scholar : PubMed/NCBI
|
31
|
Robertson S, MacKenzie SM, Alvarez-Madrazo
S, Diver LA, Lin J, Stewart PM, Fraser R, Connell JM and Davies E:
MicroRNA-24 is a novel regulator of aldosterone and cortisol
production in the human adrenal cortex. Hypertension. 62:572–578.
2013. View Article : Google Scholar : PubMed/NCBI
|
32
|
Gong JP, Yang L, Tang JW, Sun P, Hu Q, Qin
JW, Xu XM, Sun BC and Tang JH: Overexpression of microRNA-24
increases the sensitivity to paclitaxel in drug-resistant breast
carcinoma cell lines via targeting ABCB9. Oncol Lett. 12:3905–3911.
2016. View Article : Google Scholar : PubMed/NCBI
|
33
|
Ho J, Ng KH, Rosen S, Dostal A, Gregory RI
and Kreidberg JA: Podocyte-specific loss of functional microRNAs
leads to rapid glomerular and tubular injury. J Am Soc Nephrol.
19:2069–2075. 2008. View Article : Google Scholar : PubMed/NCBI
|
34
|
Shi S, Yu L, Chiu C, Sun Y, Chen J,
Khitrov G, Merkenschlager M, Holzman LB, Zhang W, Mundel P and
Bottinger EP: Podocyte-selective deletion of dicer induces
proteinuria and glomerulosclerosis. J Am Soc Nephrol. 19:2159–2169.
2008. View Article : Google Scholar : PubMed/NCBI
|
35
|
Dhandapani MC, Venkatesan V, Rengaswamy
NB, Gowrishankar K, Nageswaran P and Perumal V: Association of ACE
and MDR1 gene polymorphisms with steroid resistance in children
with idiopathic nephrotic syndrome. Genet Test Mol Biomarkers.
19:454–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
36
|
Yu-Shengyou and Li Y: Dexamethasone
inhibits podocyte apoptosis by stabilizing the PI3K/Akt signal
pathway. Biomed Res Int. 2013:3269862013. View Article : Google Scholar : PubMed/NCBI
|
37
|
Teng J, Sun F, Yu PF, Li JX, Yuan D, Chang
J and Lin SH: Differential microRNA expression in the serum of
patients with nephrotic syndrome and clinical correlation analysis.
Int J Clin Exp Pathol. 8:7282–7286. 2015.PubMed/NCBI
|